Absorption, Distribution, Metabolism, and Elimination (ADME) constitute the fundamental pharmacokinetic processes that govern the fate of drugs within the human body.
Absorption initiates the journey as the drug enters the bloodstream, influenced by factors like formulation and administration route.
Distribution guides the drug to target tissues, determined by blood flow, permeability, and binding characteristics.
Metabolism, predominantly in the liver, transforms the drug into metabolites, facilitating elimination and enhancing water solubility.
Elimination, occurring through renal excretion, hepatic excretion, and other routes, marks the final phase.
Bioavailability, half-life, and first-pass metabolism are pivotal parameters influencing drug efficacy, dosage frequency, and duration of action. The intricate interplay of these processes underscores the concept of pharmacokinetics, essential for comprehending drug behavior. Variability in individual factors, drug interactions, and the emergence of adverse reactions further emphasize the need for meticulous consideration of ADME in drug development and clinical application. Prodrugs and therapeutic drug monitoring underscore the innovative approaches to drug design and optimization, ensuring both efficacy and safety. Regulatory bodies demand a thorough understanding of ADME parameters during drug evaluation, emphasizing its critical role in shaping pharmaceutical landscapes.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada